Medical Xpress - Cardiology
NOVEMBER 20, 2024
Trendy weight-loss drugs making headlines for shrinking waistlines may also be shrinking the human heart and other muscles, according to a new University of Alberta study in JACC: Basic to Translational Science. The authors say the research should serve as a "cautionary tale" about possible long-term health effects of these drugs.
Med Page Today
NOVEMBER 20, 2024
(MedPage Today) -- Since the modern practice of anesthesia has evolved, providers have been concerned about pulmonary aspiration -- when gastric contents enter the lung, resulting in severe complications including pneumonitis, and aspiration.
Science Daily - Heart Disease
NOVEMBER 20, 2024
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals.
Med Page Today
NOVEMBER 20, 2024
(MedPage Today) -- CHICAGO -- Sacubitril/valsartan (Entresto) was effective at keeping cardiotoxicity at bay in high-risk people receiving anthracycline chemotherapy in the SARAH trial. Cancer patients were less likely to have a greater than.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
In a new study published in the European Heart Journal, researchers at Karolinska Institutet show that genetic traits influence the cellular composition of atherosclerotic plaques, which over time will affect the risk of such lesions for causing a stroke or heart attack. The new knowledge can be used to improve the risk assessment and treatment of patients with atherosclerosis in the future.
Med Page Today
NOVEMBER 20, 2024
(MedPage Today) -- CHICAGO -- Metformin with or without lifestyle modification did not reduce daily atrial fibrillation (Afib) burden over standard of care for patients with implanted heart devices, the randomized TRIM-AF trial showed. In fact.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
The prevalence of high total cholesterol was 11.3% among U.S. adults from August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
A team of researchers at the University of California San Diego has developed a new and improved wearable ultrasound patch for continuous and noninvasive blood pressure monitoring. Their work marks a major milestone, as the device is the first wearable ultrasound blood pressure sensor to undergo rigorous and comprehensive clinical validation on over 100 patients.
HCPLive
NOVEMBER 20, 2024
In these guidelines compiled by the ACAAI, the AAAAI, and the AAOA, recommendations are provided to insurance companies for documentation needed for allergen immunotherapy.
The New England Journal of Medicine
NOVEMBER 20, 2024
A man with monoclonal gammopathy of undetermined significance and thrombosis was found to have a previously undetected pathogenic monoclonal antibody that activated platelets in a PF4-dependent manner.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
A new technology that allows doctors to quantify blood flow in the heart can improve their ability to diagnose potentially deadly coronary artery disease (CAD), an international study led by School of Medicine investigators has found.
American College of Cardiology
NOVEMBER 20, 2024
A unique strength of coronary computed tomography angiography (CCTA) is the ability to noninvasively detect nonobstructive and obstructive coronary plaque.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
Researchers at the University of Virginia have made a significant discovery that could change how doctors treat viral infections of the heart. The study, published in Science Advances, reveals that the heart responds to viral infections in one of three distinct ways, offering new insights that may lead to better treatments for people at risk of heart failure.
HCPLive
NOVEMBER 20, 2024
UCB has announced the FDA’s approval of bimekizumab, also known as Bimzelx, for patients with moderate-to-severe HS.
Science Daily - Heart Disease
NOVEMBER 20, 2024
Recycled pacemakers can function as well as new devices, according to a new study. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.
American College of Cardiology
NOVEMBER 20, 2024
Sudden cardiac death (SCD) in obesity is the focus of a JACC: State-of-the-Art review of the mechanisms as well as current evidence for its management, gaps in knowledge and future research, published in JACC.
HCPLive
NOVEMBER 20, 2024
Marianna Fontana, MD, PhD discusses Phase 1 interim results on the CRISPR-based gene-editing therapy, nex-z, for ATTR-CM.
American College of Cardiology
NOVEMBER 20, 2024
A State-of-the-Art review published in JACC outlines the range of potential opportunities for the incorporation of artificial intelligence (AI) in the design and implementation of cardiovascular clinical trials, as well as the limitations and potential pitfalls.
NEJM Journal Watch - Cardiology
NOVEMBER 20, 2024
Among patients with low-risk pulmonary embolism, 18 months of anticoagulation significantly reduced its recurrence, compared with 6 months of treatment.
HCPLive
NOVEMBER 20, 2024
This analysis evaluated the frequency of peanut-sensitized infants and toddlers being sensitized to other types of nuts.
American College of Cardiology
NOVEMBER 20, 2024
In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM).
HCPLive
NOVEMBER 20, 2024
The panel of experts focus on strategies for distinguishing primary biliary cholangitis (PBC) from other liver diseases with similar clinical presentations, emphasizing key diagnostic markers and assessment techniques.
Science Daily - Heart Disease
NOVEMBER 20, 2024
Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to a new study. Researchers find that in East and West Sub-Saharan Africa, East and Central Asia and Oceania, ischemic heart disease is increasing, which may be attributed to eight factors that include diet, high BMI, household air pollution and more.
American College of Cardiology
NOVEMBER 20, 2024
Which genetic and cardiovascular risk factors are aortic stenosis (AS)-specific, and which could be shared between AS and with coronary artery disease (CAD)?
Cardiovascular Diabetology
NOVEMBER 20, 2024
Insulin resistance coexist with many metabolic disorders, whether these disorders were promotors or pathway-factors for the association of insulin resistance and cardiovascular disease (CVD) remained unclear.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
Monash University drug discovery researchers have found that a natural fat molecule called "lipoxin A4" (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.
Cardiovascular Diabetology
NOVEMBER 20, 2024
Objectives This study aimed to investigate the impact of hepatic steatosis on cardiometabolic outcomes in young adults with prediabetes. Methods A nationwide cohort study was conducted with 896,585 young adults under 40 years old without diabetes or previous history of cardiovascular disease. Hepatic steatosis was identified using a fatty liver index of ≥ 60.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
A new study exploring the use of cranial accelerometry (CA) headsets for the prehospital detection of large-vessel occlusion (LVO) strokes has been published in Academic Emergency Medicine.
Journal of Cardiothoracic Surgery
NOVEMBER 20, 2024
To explore the value of our protocol of respiratory endoscopy intervention in the treatment of refractory persistent air leakage(PAL) after pulmonary surgery.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to research in PLOS Global Public Health. Wanghong Xu of Fudan University and colleagues find that in East and West Sub-Saharan Africa, East and Central Asia and Oceania, ischemic heart disease is increasing, which may be attributed to eight factors that include diet, high BMI, household air pollution and more.
HCPLive
NOVEMBER 20, 2024
Data from 2 studies presented at ACR 2024 demonstrate the potential of AI to improve access to quality rheumatological assessments.
Med Page Today
NOVEMBER 20, 2024
(MedPage Today) -- CHICAGO -- Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients with heart failure with reduced ejection fraction (HFrEF) during spironolactone optimization.
HCPLive
NOVEMBER 20, 2024
Stephen Nicholls, MBBS, PhD, provides additional insight into KRAKEN trial data and the potential of muvalaplin.
Medical Xpress - Cardiology
NOVEMBER 20, 2024
For the four in 10 patients with newly diagnosed heart failure who also have the heart rhythm disorder atrial fibrillation, the prognosis can be poor.
HCPLive
NOVEMBER 20, 2024
Stephen J. Nicholls, MD, PhD discusses the robust efficacy and tolerability of zerlasiran for Lp(a) lowering, paving the way for Phase 3 development.
HeartRhythm
NOVEMBER 20, 2024
Recurrence after atrial fibrillation (AF) ablation is frequent. Monitoring with (long-term) electrocardiograms (ECG) is constrained by limited monitoring time, measurement dispersion, and cost. Selected photoplethysmography (PPG) smartphone applications have demonstrated excellent accuracy for AF detection and could mitigate these limitations.
HCPLive
NOVEMBER 20, 2024
The panel of experts examine major complications and comorbidities associated with primary biliary cholangitis (PBC), including vitamin deficiencies, osteoporosis, and conditions like metabolic-associated steatohepatitis (MASH), autoimmune disorders, and obesity.
Expert insights. Personalized for you.
143 
Let's personalize your content